Literature DB >> 3161422

A comparison of fentanyl-O2 and sufentanil-O2 for cardiac anesthesia.

M B Howie, T D McSweeney, R P Lingam, S P Maschke.   

Abstract

In a prospective randomized study of 48 patients scheduled to undergo elective coronary artery surgery, sufentanil (20 micrograms/kg) was compared with fentanyl (100 micrograms/kg) anesthesia by assessing hemodynamic and plasma catecholamine level responses to surgery. At 15 points during the study, cardiovascular dynamics were recorded. At six points in the study, arterial blood was obtained for simultaneous assays of plasma concentrations of epinephrine, norepinephrine, and dopamine. Neither mean cardiovascular dynamics nor catecholamine concentrations were statistically significantly different between the groups preoperatively. Both agents provided generally stable hemodynamics during surgery. Sufentanil was associated with decreased systemic vascular resistance at several time points with concurrent increased cardiac index and heart rate. Although catecholamine levels increased somewhat during cardiopulmonary bypass in both groups, there were no significant differences between the groups at any point except that at chest closure patients given sufentanil had significantly lower dopamine concentrations than those given fentanyl. Times for recovery from surgery failed to show any difference between the two groups of patients. Blood pressure increases with patients given sufentanil compared favorably with those given fentanyl. We conclude that at these doses, with this surgery, there were no major clinical differences, though sufentanil produced significantly lower systemic vascular resistance at several events and had a lower plasma dopamine concentration after cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161422

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

1.  Persistent endocrine stress response in patients undergoing cardiac surgery.

Authors:  A Roth-Isigkeit; J Brechmann; L Dibbelt; H H Sievers; W Raasch; P Schmucker
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

Review 2.  Sufentanil. A review of its pharmacological properties and therapeutic use.

Authors:  J P Monk; R Beresford; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

3.  Cardiovascular effects of different infusion rates of sufentanil in patients undergoing coronary surgery.

Authors:  M Borenstein; R Shupak; R Barnette; G Cooney; W Johnson; T B Tzeng
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

4.  Midazolam-sufentanil anaesthesia for phaeochromocytoma resection.

Authors:  J D Shapiro; A el-Ganzouri; P F White; A D Ivankovich
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

5.  Haemodynamic interactions of muscle relaxants and sufentanil in coronary artery surgery.

Authors:  D Côté; R Martin; J P Tétrault
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

6.  Are "clean" muscle relaxants better?

Authors:  I R Thomson
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

7.  Effect of fentanyl on ischemic depolarization and ischemic neuronal damage of hippocampal CA1 in the gerbil.

Authors:  Kensuke Shiraishi; Yoshimasa Takeda; Kenichi Masui; Hideki Taninishi; Toshihiro Sasaki; Tetsuya Danura; Kiyoshi Morita
Journal:  J Anesth       Date:  2011-04-21       Impact factor: 2.078

8.  A randomized double-blind comparison of fentanyl and sufentanil anaesthesia for coronary artery surgery.

Authors:  I R Thomson; R J Hudson; M Rosenbloom; R C Meatherall
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

9.  Contribution of muscle relaxant to the haemodynamic course of high-dose fentanyl anaesthesia: a comparison of pancuronium, vecuronium and atracurium.

Authors:  J Heinonen; M Salmenperä; M Suomivuori
Journal:  Can Anaesth Soc J       Date:  1986-09

10.  Anaesthesia for coronary artery bypass surgery supplemented with subarachnoid bupivacaine and morphine: a report of 18 cases.

Authors:  R J Kowalewski; C L MacAdams; C J Eagle; D P Archer; B Bharadwaj
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.